Watchlist Price Alert

Zosano Pharma Corporation (ZSAN)

NASDAQ: ZSAN · Real-Time Price · USD

0.56

0.00 (0.43%)

At close: Apr 24, 2025, 3:47 PM

Zosano Pharma Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	659K	785K	922K	670K	482K	224K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	95K
Cost of Revenue	720K	796K	875K	535K	333K	171K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-61K	-11K	47K	135K	149K	53K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	95K
Operating Income	-56.82M	-31.53M	-32.55M	-32.48M	-32.21M	-32.76M	-33.57M	-34.6M	-36.31M	-37.2M	-38.7M	-37.4M	-36.8M	-35.37M	-32.48M	-31.94M	-29.69M	-28.37M	-28.47M	-27.89M	-27.58M	-28.63M	-28.36M	-29.58M	-30.02M
Interest Income	4K	3K	3K	4K	9K	18K	21K	60K	137K	207K	337K	296K	214K	134K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-55.19M	-29.93M	-31.05M	-31.07M	-32.82M	-33.37M	-34.21M	-35.39M	-36.85M	-37.59M	-38.8M	-37.1M	-36.58M	-35.36M	-32.7M	-32.4M	-30.31M	-29.11M	-29.36M	-28.94M	-28.71M	-29.83M	-29.73M	-30.9M	-31.96M
Net Income	-55.32M	-29.98M	-31.05M	-31.07M	-32.82M	-33.37M	-34.21M	-35.39M	-36.85M	-37.59M	-38.8M	-37.1M	-36.58M	-35.36M	-32.7M	-32.4M	-30.31M	-29.11M	-29.36M	-28.94M	-28.71M	-29.83M	-29.73M	-30.9M	-31.96M
Selling & General & Admin	10.68M	10.55M	10.93M	11.11M	10.92M	11.19M	11.65M	12.02M	12.02M	11.81M	11.18M	10.46M	9.97M	9.36M	8.72M	8.4M	8.32M	8.18M	8.38M	8.36M	8.12M	8.18M	7.66M	7.36M	7.19M
Research & Development	20.13M	20.97M	21.67M	21.51M	21.44M	21.62M	21.91M	22.57M	24.28M	25.39M	27.01M	26.43M	26.32M	25.51M	23.75M	23.54M	21.37M	20.19M	20.09M	19.53M	19.46M	20.46M	20.71M	22.21M	22.92M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	30.8M	31.52M	32.6M	32.62M	32.36M	32.81M	33.57M	34.6M	36.31M	37.2M	38.19M	36.89M	36.28M	34.86M	32.48M	31.94M	29.69M	28.37M	28.47M	27.89M	27.58M	28.63M	28.36M	29.58M	30.11M
Interest Expense	165K	189K	294K	442K	610K	719K	727K	843K	688K	523K	390K	109K	74K	33K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	316K	316K	589K	1.48M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	31.52M	32.32M	33.47M	33.15M	32.69M	32.98M	33.57M	34.6M	36.31M	37.2M	38.19M	36.89M	36.28M	34.86M	32.48M	31.94M	29.69M	28.37M	28.47M	27.89M	27.58M	28.63M	28.36M	29.58M	30.11M
Income Tax Expense	1.92M	1.85M	1.79M	1.85M	-2K	108K	84K	53K	142K	131K	296K	404K	291K	49K	-225K	-462K	-626K	-735K	-895K	-1.05M	-1.13M	-883K	-1.05M	-735K	-464K
Shares Outstanding (Basic)	4.25M	118.99M	115.77M	108.94M	104.36M	102.07M	77.88M	54.93M	36.27M	19.41M	17.83M	16.87M	11.97M	11.97M	11.97M	11.75M	1.97M	1.97M	1.96M	1.96M	1.02M	840.8K	712.95K	600.6K	598.35K
Shares Outstanding (Diluted)	4.25M	118.99M	115.77M	108.94M	104.36M	102.07M	77.88M	54.93M	36.27M	19.41M	17.83M	16.87M	11.97M	11.97M	11.97M	11.75M	1.97M	1.97M	1.96M	1.96M	1.02M	840.8K	712.95K	600.6K	598.35K
EPS (Basic)	-8.07	-0.27	-0.29	-0.32	-0.41	-0.57	-0.95	-1.39	-1.8	-2.35	-2.74	-2.87	-3.07	-6.44	-9.39	-12.72	-15.41	-18.13	-23.55	-29.99	-37.41	-44.09	-47.65	-51.61	-53.44
EPS (Diluted)	-8.07	-0.27	-0.29	-0.32	-0.41	-0.57	-0.95	-1.39	-1.8	-2.35	-2.74	-2.87	-3.07	-6.44	-9.39	-12.72	-15.41	-18.13	-23.55	-29.99	-37.41	-44.09	-47.65	-51.61	-53.44
EBITDA	-53.46M	-27.98M	-29M	-28.85M	-30.52M	-31.22M	-32.95M	-34.1M	-35.67M	-36.38M	-37.12M	-35.86M	-35.57M	-34.56M	-31.43M	-30.72M	-28.2M	-26.55M	-26.79M	-26.38M	-26.16M	-26.97M	-26.93M	-27.88M	-28.04M
EBIT	-14.77M	-22.82M	-30.76M	-30.63M	-32.21M	-32.65M	-33.48M	-34.54M	-36.16M	-37.07M	-38.41M	-28.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	1.57M	1.75M	1.76M	1.78M	1.69M	1.43M	539K	440K	495K	683K	1.29M	1.13M	930K	764K	1.26M	1.68M	2.12M	2.55M	2.58M	2.56M	2.55M	2.54M	2.48M	2.43M	2.44M